Find insight on Doosan Fuel Cell, XRG, Santos and more in the latest Market Talks covering Energy and Utilities.

Johnson & Johnson said the first clinical data from its ongoing Phase 1b study of JNJ-4496, a chimeric antigen receptor T-cell therapy, shows encouraging potential in treating large B-cell ...

Dow Inc. (DOW) ended the recent trading session at $27.15, demonstrating a +1.23% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily gain of 0.8%.

Dow Inc. (NYSE:DOW) and X-Energy Reactor said Monday they submitted a construction permit application to the Nuclear Regulatory Commission for a proposed advanced nuclear project in Seadrift ...

Shares of Sana Biotechnology jumped after the company reported positive results for the latest study transplanting its UP421 cell therapy into a patient with type 1 diabetes. The stock was up 21% at ...

Amgen said interim results from a Phase 3 trial showed Imdelltra reduced the risk of death and other benefits for patients with small cell lung cancer.